Are you a victim of Pradaxa internal bleeding? Lawsuits claiming that the widely-prescribed blood thinner puts patients at risk of serious internal hemorrhaging are moving forward in courts throughout the U.S. The U.S. Food & Drug Administration (FDA), along with regulators in Europe, Japan and New Zealand, have all issued Pradaxa bleeding warnings since the drug was brought to market in 2010. According to statistics from the FDA, the agency received reports of 542 Pradaxa deaths and 3,781 side-effect incidents tied to the drug in 2011. The Institute of Safe Medication Practices has also reported that Pradaxa generated more reports of injury or death than any of the 800 drugs it monitors.
Pradaxa bleeding can occur spontaneously, or from a minor trauma, such as a fall. In March 2012, the Journal of Neurosurgery detailed a case in which an elderly man suffered a minor fall that resulted in a fatal case of Pradaxa brain bleeding. There are some concerns that the elderly, who make up a large percentage of Pradaxa users, may be more vulnerable to the drug’s bleeding side effects. Many elderly are more prone to falls, and often have other medical conditions that make internal bleeding more dangerous and Pradaxa death far more likely.
All blood thinners carry a risk of internal bleeding. However, there exists no readily-available antidote for Pradaxa bleeding. Bleeding from the blood thinner warfarin, by contrast, can be stopped via the administration of vitamin k. While dialysis can be used to remove Pradaxa from the blood stream, this treatment is risky and may not be administered in time to stop Pradaxa internal bleeding.
Because Pradaxa bleeding can quickly become life-threatening, it is important that patients taking the blood thinner be aware of the signs and symptoms of Pradaxa brain bleeding, gastrointestinal hemorrhaging and other internal bleeding. You must seek treatment immediately if you use Pradaxa and experience any of the following:
A multidistrict litigation for what could eventually be thousands of Pradaxa bleeding lawsuits has been established in U.S. District Court, Southern District of Illinois. Claims pending in this litigation allege Boehringer Ingelheim Pharmaceuticals, Inc. failed to provide adequate warnings about the risk for life-threatening bleeding associated with Pradaxa, as well as the lack of an antidote. The first trial in the federal Pradaxa litigation is expected to begin in the summer of 2014.
Victims of Pradaxa internal bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and other damages. The attorneys at Bernstein Liebhard LLP are offering free case evaluations to anyone who experienced dangerous Pradaxa bleeding. To learn more about the process for filing a Pradaxa lawsuit, please contact one of our attorneys today by calling .